Proto Script Pharmaceutical (Proto Script Pharmaceutical) ROCE % : 0.00% (As of Sep. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Proto Script Pharmaceutical's annualized ROCE % for the quarter that ended in Sep. 2017 was 0.00%.

Proto Script Pharmaceutical ROCE % Historical Data

The historical data trend for Proto Script Pharmaceutical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical ROCE % Chart

Proto Script Pharmaceutical Annual Data

Trend

May12

May13

May14

May15

May16

ROCE %

-193.94

-160.98

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
ROCE %	Get a 7-Day Free Trial															-	-	-	-	-

Proto Script Pharmaceutical ROCE % Calculation

Proto Script Pharmaceutical's annualized ROCE % for the fiscal year that ended in May. 2016 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: May. 2016 )		(A: May. 2015 )		(A: May. 2016 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: May. 2016 )		(A: May. 2015 )		(A: May. 2016 )
	=	-0.033	/	( ( (0.001 - 0.045)	+	(0.012 - 0.089) )	/ 2 )
	=	-0.033	/	( (-0.044	+	-0.077)	/ 2 )
	=	-0.033	/	-0.0605
	=	54.55 %

Proto Script Pharmaceutical's ROCE % of for the quarter that ended in Sep. 2017 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2017 )		(Q: Jun. 2017 )		(Q: Sep. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2017 )		(Q: Jun. 2017 )		(Q: Sep. 2017 )
	=	-0.664	/	( ( (0.166 - 1.324)	+	(0.235 - 1.676) )	/ 2 )
	=	-0.664	/	( ( -1.158	+	-1.441 )	/ 2 )
	=	-0.664	/	-1.2995
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2017) EBIT data.

Proto Script Pharmaceutical (OTCPK:PSCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Proto Script Pharmaceutical ROCE % Related Terms

Thank you for viewing the detailed overview of Proto Script Pharmaceutical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730

Website

http://www.psphomecare.com

Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines